Pfizer shells out $225mm plus contingent milestones for InnoPharma
In the wake of its failed bid for AstraZeneca, Pfizer Inc. paid $225mm up front in cash and another $135mm in possible earn-outs to acquire privately held InnoPharma Inc., which specializes in generics and drug delivery.
- Drug Delivery
- Generic Drugs
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com